Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).

Luis Paz‐Ares, Dariusz M. Kowalski, Ali Tafreshi et al.|Journal of Clinical Oncology|2018

Cited by 121